Collaboration Station

Where CMI, Compas, Singularity, InfoCures, & MEDtrak Come Together!

The Scoop – Combating Ad Fraud | Fueling Drug Development | Retail Innovation May 6, 2014

Filed under: Corporate — CMI/Compas @ 3:59 pm

The big buzz yesterday was around this article showing the dangers of ad fraud; this is a major industry issue, but stands as a reminder of the steps CMI/Compas has taken to protect our clients, which include a best-in-class ad verification system that includes our partnership with comScore, as well as our best-in-class in-house analytics team, IQ Rx, which helps us ensure we’re achieving our engagement goals. We’ve got you covered.

Reuters reports: “Leading global pharmaceutical companies have started to view their vast portfolios of older, established prescription drugs as vehicles for raising large sums of cash to fuel development of new medicines with far higher profit margins. France’s Sanofi and U.S. drugmakers Merck & Co and Abbott Laboratories are exploring selling off their mature drugs that have lost patent protection…”

Eight years after Massachusetts passed a health care law that became a model for Obamacare, a study published in the Annals of Internal Medicine has found the results have been positive from a health perspective. The study found that deaths from preventative and treatable conditions dropped 4.5% and overall deaths in Massachusetts dropped 3%.

Attention, shoppers – Amazon and Google are launching technologies that are kinda mind-blowing. Amazon now lets you tweet products into your shopping cart. Google can alert you if you are near a product that you’ve researched online. Also, in some areas, Google will deliver, same day and for free (in fact, you may even earn loyalty points) groceries and other purchases.

Speaking of tech innovation, Olympus’s much-hyped pill-sized camera has been approved, to the benefit of GI patients and over-sharers.

-Carly Kuper, VP, Strategic Marketing & Corporate Communications
Did you like today’s Scoop? Sign up here or email us at to receive it daily.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s